Theme · live manifest · live theme JSON
Biotech '25: Oncology & Immunotherapy
12 tickers · $64.44B total market cap
Group: Biotech
Biotech '25: Oncology & Immunotherapy tracks 12 publicly listed stocks in this theme: ACLX, AVBP, CGEM, CRSP, JANX, NRIX, NUVB, NUVL, PTGX, RIGL, RVMD, ZYME. See the constituent table for details.
Constituents
Build 20260520T081747
| Company | Previous Quarter Report Date | Next Expected Report Date | Last Quarter Earnings Move % | Earnings Move % | Intra-Quarter Move % | Since Last Report % | Market cap | Weight |
|---|---|---|---|---|---|---|---|---|
Revolution Medicines, Inc.RVMD | 05/06/2026 (AMC) | 05/06/2026 (AMC) | -1.18% | -3.19% | 48.08% | 3.36% | $31.31B | 8.3333 |
Nuvalent, Inc.NUVL | 05/07/2026 (BMO) | 05/07/2026 (BMO) | -2.47% | 0.98% | 2.27% | -4.07% | $7.43B | 8.3333 |
Arcellx, Inc.ACLX | 02/26/2026 (AMC) | — | -0.08% | — | 1.12% | — | $6.73B | 8.3333 |
Protagonist Therapeutics, Inc.PTGX | 05/05/2026 (AMC) | 05/05/2026 (AMC) | 5.72% | 4.47% | 7.74% | -5.39% | $6.33B | 8.3333 |
CRISPR Therapeutics AGCRSP | 05/04/2026 (AMC) | 05/04/2026 (AMC) | 8.46% | 1.45% | 0.96% | -9.14% | $4.59B | 8.3333 |
Zymeworks Inc.ZYME | 05/07/2026 (AMC) | 05/07/2026 (AMC) | 8.24% | -13.47% | 5.43% | 2.13% | $1.80B | 8.3333 |
Nuvation Bio Inc.NUVB | 05/04/2026 (AMC) | 05/04/2026 (AMC) | -18.84% | 7.57% | -6.96% | -12.22% | $1.47B | 8.3333 |
Nurix Therapeutics, Inc.NRIX | 04/08/2026 (AMC) | 04/08/2026 (AMC) | -7.55% | -0.67% | -5.57% | -6.16% | $1.32B | 8.3333 |
ArriVent BioPharma, Inc. Common StockAVBP | 05/11/2026 (AMC) | 05/11/2026 (AMC) | -7.21% | -1.80% | 23.86% | -9.73% | $1.22B | 8.3333 |
Cullinan Therapeutics, Inc.CGEM | 05/07/2026 (BMO) | 05/07/2026 (BMO) | -6.53% | -2.94% | 4.75% | -2.58% | $871.2M | 8.3333 |
Janux Therapeutics, Inc.JANX | 05/07/2026 (AMC) | 05/07/2026 (AMC) | -1.38% | -3.04% | 6.83% | -2.57% | $842.2M | 8.3333 |
Rigel Pharmaceuticals, Inc.RIGL | 05/05/2026 (AMC) | 05/05/2026 (AMC) | -10.60% | -9.72% | -4.84% | 6.11% | $523.6M | 8.3333 |
| Average | -2.78% | -1.85% | 6.97% | -3.66% | $5.37B | 8.3333 | ||
| Median | -1.92% | -1.80% | 3.51% | -4.07% | $1.63B | 8.3333 | ||
| Std Dev | 7.68% | 5.64% | 14.62% | 5.48% | $8.20B | 0.0% | ||
| Min | -18.84% | -13.47% | -6.96% | -12.22% | $523.6M | 8.3333 | ||
| Max | 8.46% | 7.57% | 48.08% | 6.11% | $31.31B | 8.3333 | ||
| % Positive Tickers | 25.00% | 36.36% | 75.00% | 27.27% |
* Provisional value: before LstRpt% reaches its 2-day post-report lock window (BMO/AMC adjusted), EarningsPerf is calculated from current vs pre-report and then locks to final LstRpt%.